http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2649497-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6b0bf6c3d9f24abfad81f059eb3aad |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865f96f8af04d8663effac037186c3b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6221ac7f260cf48ec08c4ae305303983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a286e28f85d195db4e2e8beeb09463ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12bdd3d87db1f9241bb0084a59e136a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac0fac4fd346592cbd2aee36b98ad2a |
| publicationDate | 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2649497-C1 |
| titleOfInvention | Method for the risk of forming chronic heart failure evaluating in young men, suffering from arterial hypertension |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to cardiology and can be used to assess the risk of chronic heart failure in young men with arterial hypertension. Determining the cardiotrophin-1 plasma concentration. Determining the ratio of the maximum velocities of the transmittal blood flow at the beginning and end of the diastole (E/A) initially and at the height of hyperglycemia when an intravenous load by an individual standardized dose of glucose is administered. Calculating the value of the glucose-induced change in E/A as the modulus of the E/A difference, defined initially and at the height of hyperglycemia. If the value of the glucose-induced change in E/A is greater than or equal to 0.5, 1 point is awarded, less than 0.5 is 0 points. With a cardiotrophin-1 plasma concentration greater than or equal to 200 pg/ml, 1 point is awarded, less than 200 pg/ml 0 points are awarded. Summarizing the points. With a score of 2, a high risk of chronic heart failure developing is predicted. With a score of 1, a moderate risk of chronic heart failure developing is predicted. With a score of 0, a low risk of chronic heart failure developing is predicted. n EFFECT: method makes it possible to predict the chronic heart failure formation in young men, suffering from arterial hypertension due to the evaluation of the most significant indicators. n 1 cl, 2 ex |
| priorityDate | 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.